Despite presidential candidates promising to reduce the out-of-pocket costs of prescription drugs, a new article from STAT makes the case that the amount of power the government actually has to drive down drug prices on a large scale may not be significant.
With a small window of time before the U.S. Presidential elections take all the legislative air out of the room, medical advocacy groups are focused on advancing their top priorities. The majority of this year's goals lie in the regulatory arena, according to a story in MedPage Today.
Medicare enrollees at critical access hospitals often pay far more out of pocket than patients obtaining the same care at larger institutions, according to an analysis by The Wall Street Journal.
New research indicates that cost may be an important barrier to colorectal cancer screenings, at least among men, and that changing policies to close the remaining loopholes that would reduce the expected out-of-pocket expenses for all Medicare beneficiaries may improve screening rates.
It's a headline some worried would never appear, but repeal of Medicare's sustainable growth rate formula finally became reality in 2015. Of course, as we bid adieu to the SGR, a new dilemma took its place, making our story comparing the upcoming merit-based incentive payment system and alternative payment model among our most popular stories this year.
Medicare will provide complete data at the national level to a San Francisco-based for-profit start-up company with the goal of providing the most accurate physician information to patients so they can make the best decisions for their healthcare needs, according to an article from U.S. News & World Report.
Americans should expect to have longer lifespans, but those lives will be accompanied by an increase in conditions such as diabetes, hypertension and other ailments that are expected to drive up the cost of their care, according to a study by researchers at the University of Southern California.
Regions of the country that spend less through the Medicare program do not necessarily have lower healthcare costs as a whole, upending conventional wisdom about healthcare spending patterns.
Whatever its flaws, Medicare is one of the few voices of rationality in healthcare finance. Due to the system's huge amount of leverage--it covers about 55 million Americans--it is able to...
While spending on prescription drugs accounts for only 10 percent of national spending on health, it makes up almost 19 percent of spending for employer health plans, writes Kaiser Family Foundation President and CEO Drew Altman writes in a blog post for the Washington Post.